JL Ingram, M Kraft - Journal of Allergy and Clinical Immunology, 2012 - Elsevier
Decades of research in animal models have provided abundant evidence to show that IL-13 is a key TH2 cytokine that directs many of the important features of airway inflammation and …
H Kimura, D Francisco, M Conway, FD Martinez… - Journal of Allergy and …, 2020 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has dramatically changed our world, country, communities, and families. There is controversy …
Barrier tissue dysfunction is a fundamental feature of chronic human inflammatory diseases 1. Specialized subsets of epithelial cells—including secretory and ciliated cells …
CB Morrison, CE Edwards, KM Shaffer… - Proceedings of the …, 2022 - National Acad Sciences
Muco-obstructive lung diseases are typically associated with high risks of COVID-19 severity; however, allergic asthma showed reduced susceptibility. To investigate viral …
There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS …
Aberrant cell signaling can cause cancer and other diseases and is a focal point of drug research. A common approach is to infer signaling activity of pathways from gene …
Background Interleukin 13 is a central mediator of asthma. Tralokinumab is a human interleukin-13 neutralising monoclonal antibody. We aimed to assess the efficacy and safety …
X Li, SA Christenson, B Modena, H Li… - Journal of Allergy and …, 2021 - Elsevier
Background The Chr17q12-21.2 region is the strongest and most consistently associated region with asthma susceptibility. The functional genes or single nucleotide polymorphisms …
Y Fang, Y Tang, B Huang - Seminars in Immunology, 2023 - Elsevier
The goal of cancer immunotherapy is to clear tumor cells by activating antitumor immunity, especially by mobilizing tumor-reactive CD8+ T cells. Pyroptosis, programmed lytic cell …